newsfilter
← Latest News
GlobeNewswire·

Ambrx Presents New Preclinical Data on ARX517 and ARX305 at the 2023 AACR Annual Meeting

SAN DIEGO, April 19, 2023 (GLOBE NEWSWIRE) -- Ambrx Biopharma Inc., or Ambrx (NASDAQ:AMAM), announced new preclinical data at the 2023 American Association for Cancer Research (AACR) Annual Meeting in Orlando, Florida,